Marsh & McLennan Companies reported a 10% rise in adjusted earnings per share to $2.03 and an 8% increase in revenue to $6.86 billion for Q3, surpassing analyst expectations. Growth was driven by strong performance in the risk services and consulting divisions, with risk division revenue up 10% and consulting revenue up 9%. The company showed resilience despite challenges in the commercial insurance market, with underlying revenue growth of 5% and improved profitability. These results suggest Marsh McLennan can continue delivering growth across its core businesses.
Marsh & McLennan Companies shares saw a 6.56% increase in price to USD 190.10, with a typical hold time on Pluang of 109 days and Pluang order activity showing 100% sell today. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Oct 15, 2026 21:41 WIB: out of 142 stocks, 98 rose and 44 fell. Other notable movers include Hut 8 Corp down 8.72% and TeraWulf Inc down 6.50%.
The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...
Alice collaborated with Inflection AI and AI21 to demonstrate that NVIDIA Nemotron open models can be post-trained using real-world adversarial data to enhance AI safety and security without losing capability. Inflection AI improved conversational AI...
Stifel Nicolaus has reiterated a Buy rating for Accenture with a price target of $242, reflecting confidence in the company's strong recent stock performance and growth prospects. Accenture's shares rose 13.4% in the month leading up to October 15, 2...
Investment firm William Blair downgraded CCC Intelligent Solutions to Market Perform amid news of a $6.1 billion acquisition by a consortium led by GTCR and Elliott Investment Management. Shareholders will receive $7.75 per share, a premium over rece...
U.S. Bancorp reported third-quarter 2026 earnings per share of $1.34, exceeding analyst estimates of $1.32 and marking its fourth consecutive earnings beat. Revenue grew 8.8% year-over-year to $7.97 billion but fell just short of the $8.00 billion ex...
